中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
8期
26-27
,共2页
心力衰竭%胺碘酮%美托洛尔
心力衰竭%胺碘酮%美託洛爾
심력쇠갈%알전동%미탁락이
Heart failure%Amiodarone%Metoprolol
目的:探讨胺碘酮联合美托洛尔治疗心力衰竭的临床疗效。方法选取2012年10月~2013年10月本院收治的心力衰竭患者160例,将其随机分为观察组和对照组各80例,对照组给予胺碘酮治疗,观察组在对照组治疗的基础上加用美托洛尔,观察两组患者的心功能改善情况,并进行疗效评定。结果观察组总有效率为98.75%,显著高于对照组的85.00%,差异有统计学意义(P<0.05)。两组治疗后SBP、DBP、HR、LVEDD、LVESD及LVEF均较治疗前改善,且治疗后观察组上述指标均优于对照组(P<0.05)。结论胺碘酮联合美托洛尔治疗心力衰竭疗效显著,心功能改善明显,值得临床推广应用。
目的:探討胺碘酮聯閤美託洛爾治療心力衰竭的臨床療效。方法選取2012年10月~2013年10月本院收治的心力衰竭患者160例,將其隨機分為觀察組和對照組各80例,對照組給予胺碘酮治療,觀察組在對照組治療的基礎上加用美託洛爾,觀察兩組患者的心功能改善情況,併進行療效評定。結果觀察組總有效率為98.75%,顯著高于對照組的85.00%,差異有統計學意義(P<0.05)。兩組治療後SBP、DBP、HR、LVEDD、LVESD及LVEF均較治療前改善,且治療後觀察組上述指標均優于對照組(P<0.05)。結論胺碘酮聯閤美託洛爾治療心力衰竭療效顯著,心功能改善明顯,值得臨床推廣應用。
목적:탐토알전동연합미탁락이치료심력쇠갈적림상료효。방법선취2012년10월~2013년10월본원수치적심력쇠갈환자160례,장기수궤분위관찰조화대조조각80례,대조조급여알전동치료,관찰조재대조조치료적기출상가용미탁락이,관찰량조환자적심공능개선정황,병진행료효평정。결과관찰조총유효솔위98.75%,현저고우대조조적85.00%,차이유통계학의의(P<0.05)。량조치료후SBP、DBP、HR、LVEDD、LVESD급LVEF균교치료전개선,차치료후관찰조상술지표균우우대조조(P<0.05)。결론알전동연합미탁락이치료심력쇠갈료효현저,심공능개선명현,치득림상추엄응용。
Objective To evaluate the clinical efficacy of amiodarone combined with metoprolol in the treatment of heart failure. Methods Our hospital from October 2012 to October 2013 were treated with heart failure in 160 patients, randomly divided into into combined treatment group of 80 patients and a control group of 80 patients in the control group with amiodarone, combination therapy group received treatment based on the combination of metoprolol treatment. Results The two groups of patients treated control group improved heart function after total effective rate was 98.7%, the combined treatment group was 85.00%. The difference was significant (P<0.05). Conclusion The combined amiodarone and metoprolol treatment of heart failure has good clinical efficacy in improve cardiac function is superior to amiodarone alone group.It is worthy of clinical application.